Relevance of proliferative and pro-apoptotic factors in nan-small-cell lung cancer for patient survival

British Journal of Cancer

Volumn 82, Issue 10, 2000, Pages 1747-1754

  Volm, M ^a   Koomagi R ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; Non small cell lung carcinomas; Prognosis; Proliferation; Survival

Indexed keywords

CASPASE 3; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLINE; FAS ANTIGEN; FAS LIGAND;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIGENS, CD95; APOPTOSIS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL DIVISION; FAS LIGAND PROTEIN; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0034060638     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Cardon-Cardo C (1995) Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia (review). Am J Pathol 147: 545-560
2. Ebina M, Steinberg SM, Mulshine JL and Linnoila RI (1994) Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small-cell lung cancer. Cancer Res 54: 2496-2503
3. Fernandez-Alnemri T, Litwack G and Alnemri ES (1994) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death Ced-3 and mammalian interleukin-1β-converting enzyme. J Biol Chem 269: 30761-30764
4. Fisher DE (1994) Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539-542
5. Garcia RL, Coltera MD and Gown AM (1989) Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Am J Pathol 134: 733-773
6. Haag D (1980) Flow microfluorometric deoxyribonucleic acid (DNA) analysis supplementing routine histopathologic diagnosis of biopsy specimens. Lab Invest 42: 85-90
7. Hall PA and Levison DA (1990) Review: assessment of cell proliferation in histological material. J Clin Pathol 43: 184-192
8. Hellquist HB, Alejnick B, Jadner M, Andersson T and Sederholm C (1997) Fas receptor is expressed in human lung squamous cell carcinomas whereas bel-2 and apoptosis are not pronounced. A preliminary report. Br J Cancer 76: 175-179
9. Jaskulski D, De Riel JK, Mercer WE, Calabretta B and Baserga R (1988) Inhibition of cellular proliferation by antisense oligodeoxynucleolides to PCNA/cyclin. Science 240: 1544-1546
10. Kangas A, Nicholson DW and Hölttä E (1998) Involvement of CPP32/caspase-3 in c-Mye-induced apoptosis. Oncogene 16: 387-398
11. Keyomarsi K and Pardee AB (1997) Redundant cyclin over-expression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90: 1112-1116
12. Koomägi R and Volm M (1999) Expression of Fas (CD95/Apo-1) and Fas ligand in lung cancer, its prognostic and predictive relevance. Int J Cancer (Pred Oncol) 84: 239-243
13. Lew DJ and Kornbluth S (1996) Regulatory roles of cyclin-dependent kinase phosphorylation in cell cycle control. Curr Opin Cell Biol 8: 795-804
14. Michalides R, Van Veelen N, Hart A, Loftus B, Wientjens E and Balm A (1995) Overexpression of cyclin D1 correlates with recurrence in a group of fortyseven operable squamous-cell carcinomas of the head and neck. Cancer Res 55: 975-978
15. Nagata S and Golstein P (1995) The Fas death factor. Science 267: 1451-1455
16. Naitoh H, Shibata J, Kawaguchi A, Kodama M and Hattori T (1995) Overexpression and localization of cyclin D1 RNA and antigen in esophageal cancer. Am J Pathol 146: 1161-1169
17. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR. Labelle M and Lazebnik YA (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43
18. Niehans GA, Brunner T, Frizelle SP, Liston JC, Salerno CT, Knapp DJ, Green DR and Kratzke RA (1997) Human lung carcinomas express Fas ligand. Cancer Res 57: 1007-1012
19. Paterlini P, Flejou JF, DeMitri MS, Pisi E, Franco D and Brechot C (1995) Structure and expression of the cyclin A gene in human primary liver cancer. Correlation with flow cytometry parameters. J Hepatol 23: 47-52
20. Seshadri R, Lee CSL, Hui R, McCaul K, Horsfall DJ and Sutherland RL (1996) Cyclin D-1 amplification is not associated with reduced overall survival in primary breast cancer, but may predict early relapse in patients with features of good prognosis. Clin Cancer Res 2: 1177-1184
21. Tam SW, Theodoras AM, Shay JW, Draetta GF and Pagano M (1994) Differential expression and regulation of cyclin-D1 protein in normal and tumor human cells: association with cdk4 is required for cyclin-D1 function in G1 progression. Oncogene 9: 2663-2674
22. Volm M, Mattern J and Samsel B (1993) Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein and glutathione S-transferase-π inhuman lung cancer. Cancer 71: 3181-3187
23. Volm M, Stammler G, Koomàgi R and Mattern J (1996) Co-expression of cyclin D1 and retinoblastoma gene product (pRb) in human squamous cell lung carcinomas is associated with increased tumor take rate in nude mice. Int J Oncol 9: 1253-1257
24. Volm M, Koomägi R, Mattern J and Stammler G (1997a) Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas. Br J Cancer 75: 1174-1778
25. Volm M, Mattern J, Stammler G, Royer-Pokora B, Schneider S, Weirich A and Ludwig R (1997b) Expression of resistance related proteins in nephroblastoma after chemotherapy. Int J Cancer 63. 193-197
26. Xerri L, Devilard E, Hassoun J, Mawa SC and Birg F (1997) Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues. J clin Pathol Mol Path 50: 87-91
27. Zindy F, Lamas E, Chenivesse X, Sobczak I, Wang I, Fesquet D, Henglein B and Brechot C (1992) Cyclin A is required in S-phase in normal epithelial cells. Biochem Biophys Res Commun 182: 1144-1151